These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 30052618)
1. Newly Categorized Seromucinous Tumor of the Ovary: Magnetic Resonance Imaging Findings. Han JW; Kim KA; Chang HY; Kim JW; Park YS; Lee J; Choi JW; Lee CH; Park CM J Comput Assist Tomogr; 2019; 43(1):119-127. PubMed ID: 30052618 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour. Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934 [TBL] [Abstract][Full Text] [Related]
3. Transitional cell tumor of the ovary: computed tomographic and magnetic resonance imaging features with pathological correlation. Oh SN; Rha SE; Jung SE; Lee YJ; Choi BG; Byun JY; Ku YM; Jung CK J Comput Assist Tomogr; 2009; 33(1):106-12. PubMed ID: 19188796 [TBL] [Abstract][Full Text] [Related]
4. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging. Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy. Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276 [TBL] [Abstract][Full Text] [Related]
6. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance]. Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536 [No Abstract] [Full Text] [Related]
7. Magnetic resonance imaging findings of cystic ovarian tumors: major differential diagnoses in five types frequently encountered in daily clinical practice. Ohya A; Fujinaga Y Jpn J Radiol; 2022 Dec; 40(12):1213-1234. PubMed ID: 35916971 [TBL] [Abstract][Full Text] [Related]
8. A diagnostic challenge of seromucinous borderline tumor: A case report. Liu T; Sumida D; Wada T; Maehana T; Yamawaki A; Sugimoto S; Kawahara N; Yoshimoto C; Kobayashi H Medicine (Baltimore); 2019 May; 98(22):e15707. PubMed ID: 31145284 [TBL] [Abstract][Full Text] [Related]
9. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy. Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911 [TBL] [Abstract][Full Text] [Related]
10. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation. Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056 [TBL] [Abstract][Full Text] [Related]
11. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358 [TBL] [Abstract][Full Text] [Related]
12. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary. Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452 [TBL] [Abstract][Full Text] [Related]
14. MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor. Kawaguchi M; Kato H; Hatano Y; Tomita H; Hara A; Suzui N; Miyazaki T; Furui T; Morishige KI; Matsuo M Jpn J Radiol; 2020 Aug; 38(8):782-789. PubMed ID: 32246351 [TBL] [Abstract][Full Text] [Related]
15. Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms. Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M J Magn Reson Imaging; 2013 Oct; 38(4):794-801. PubMed ID: 23440747 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic study of seromucinous carcinoma of ovary]. Tang SX; Sun YH; Xu Y; Zhou XR; Yang WT Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):774-779. PubMed ID: 27821232 [No Abstract] [Full Text] [Related]
17. Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation. Park SB; Kim MJ; Lee KH; Ko Y Br J Radiol; 2018 Jul; 91(1088):20170689. PubMed ID: 29888983 [TBL] [Abstract][Full Text] [Related]
18. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature. Idrees R; Din NU; Siddique S; Fatima S; Abdul-Ghafar J; Ahmad Z J Ovarian Res; 2021 Mar; 14(1):47. PubMed ID: 33736662 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis. Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307 [TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma. Wang W; Ding J; Zhu X; Li Y; Gu Y; Peng W PLoS One; 2015; 10(7):e0132406. PubMed ID: 26161555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]